Inter Parfums (IPAR)
(Delayed Data from NSDQ)
$125.66 USD
+3.12 (2.55%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $125.51 -0.15 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$125.66 USD
+3.12 (2.55%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $125.51 -0.15 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Zacks News
Church & Dwight Touches 52-Week High on Growth Momentum
by Zacks Equity Research
Shares of Church & Dwight Co., Inc. (CHD) touched a new 52 week high of $53.79 on Jun 19, to close at $53.75.
Estee Lauder Hits 52-Week High on Stronger Beauty Portfolio
by Zacks Equity Research
Shares of Estee Lauder Companies Inc. (EL) touched a 52 week high of $98.22 on Jun 19, following its announcement to invest in Deciem ??? a fast-growing multi-brand company. Shares eventually closed the day at $98.19.
Estee Lauder (EL) Invests in DECIEM, Strengthens Portfolio
by Zacks Equity Research
In order to strengthen its beauty portfolio further, Estee Lauder Companies Inc. (EL) recently invested in DECIEM -- a fast-growing multi-brand company. However, terms of the investment were not disclosed.
Estee Lauder Hits 52-Week High on Bright Prospects in China
by Zacks Equity Research
Shares of Estee Lauder (EL) have touched a 52-week high of $96.23 on Jun 2, as analysts are bullish about the double-digit sales growth recorded in China.
Tyson Foods Prices Tender Offer for AdvancePierre Buyout
by Zacks Equity Research
Tyson Foods, Inc. (TSN) has agreed to sell its notes offering, in order to finance the previously announced acquisition of AdvancePierre Foods Holdings, Inc.
Will Estee Lauder's Strategic Efforts Help Gain Momentum?
by Zacks Equity Research
Estee Lauder Companies, Inc. (EL) has been gaining momentum of late. The company is well-positioned in the consumer product categories on the back of a strong portfolio, constant innovation and robust acquisitions.
Helen of Troy (HELE) Makes New Share Buyback Authorization
by Zacks Equity Research
Helen of Troy (HELE) has announced a new share buyback program worth $400 million.
PepsiCo Introduces Limited Edition 'Pepsi Fire' Beverage
by Zacks Equity Research
PepsiCo, Inc. (PEP) has been forging ahead with its aggressive marketing drive and research & development (R&D) investments. Recently, the company introduced the limited edition cinnamon-flavored cola "Pepsi Fire".
Coty Inc. (COTY) Earnings, Revenues Beat Estimates in Q3
by Zacks Equity Research
Coty, Inc. (COTY) posted third-quarter fiscal 2017 results, wherein both earnings and revenues beat the Zacks Consensus Estimate.
5 Consumer Staple Stocks Set to Beat this Earnings Season
by Zacks Equity Research
The sector has gained 7.6% so far and has outperformed the S&P 500 index.
Nu Skin (NUS) Q1 Earnings Beat, Sales Miss, View Intact
by Zacks Equity Research
Nu Skin (NUS) delivered positive earnings surprise in the first quarter of 2017.
Avon (AVP) Delivers Q1 Loss, Transformation Plan Looks Good
by Zacks Equity Research
Avon Products Inc. (AVP) posted adjusted loss from continuing operations of 7 cents per share for first-quarter 2017, lagging the Zacks Consensus Estimate of break-even.
Estee Lauder (EL) Stock Up on Q3 Earnings, Sales Beat
by Zacks Equity Research
Estee Lauder Companies Inc. (EL) continues to impress investors with better-than-expected earnings for the eleventh consecutive quarter, when the company reported third-quarter fiscal 2017 results.
Pilgrim's Pride (PPC) Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Pilgrim's Pride Corporation (PPC) is scheduled to report first-quarter 2017 on May 4.
Forget McCormick, Buy These 4 Consumer Staple Stocks Instead
by Zacks Equity Research
We have identified four consumer staple stocks, which not only have strong fundamentals but are also equipped with the right combination of elements to post an earnings beat.
Altria (MO) Fights Volume Decline: Should You Hold the Stock?
by Zacks Equity Research
Altria Group Inc. has been grappling with increased competition in the vapor category, declining volumes of cigarettes, strict anti-smoking regulations by governments globally and currency headwinds.
Reynolds American Likely to Bounce Back: Should You Hold?
by Zacks Equity Research
Reynolds American Inc. (RAI) performance shows that the company has been trading in the red for a while now.
Will Estee Lauder Benefit from the Too Faced Acquisition?
by Zacks Equity Research
Cosmetics giant Estee Lauder Companies Inc. (EL) has completed the acquisition of feminine cosmetics brand Too Faced.
Philip Morris Grapples with Headwinds: Should You Still Hold?
by Zacks Equity Research
Tobacco maker Philip Morris International Inc. (PM) seems to have hit a rough patch at the moment.
Estee Lauder (EL) Slips to Sell: What's Wrong with the Stock?
by Zacks Equity Research
Cosmetics giant, Estee Lauder Companies Inc. (EL) has recently slipped to the red and seems to be in troubled waters at the moment.
Avon (AVP): Can the Stock Sustain its Solid Momentum?
by Zacks Equity Research
We note that Avon Products Inc's (AVP) share price has seen an uptrend since January this year after bottoming at the end of 2015.
SUPERVALU Grappling with Headwinds: Should You Hold?
by Zacks Equity Research
Grocery retailer SUPERVALU Inc. (SVU) seems to be in a state of doldrums at the moment.
Nu Skin (NUS) Provides Weak 2016 Sales View; CEO to Exit
by Zacks Equity Research
Nu Skin Enterprises Inc. (NUS) recently updated its financial guidance for 2016, wherein it expects sluggish sales growth and also announced the exit of its Chief Executive Officer ("CEO"). Shares of Nu Skin declined 7.2% yesterday after the news. The company also provided an initial guidance for 2017.
SUPERVALU Completes Divestment of Save-A-Lot Business
by Zacks Equity Research
SUPERVALU Inc. (SVU) has completed the divestment of its Save-A-Lot business to private equity firm Onex for $1.365 billion in cash.
Top Ranked Growth Stocks to Buy for November 10th
by Zacks Equity Research
Here are four stocks with a Zacks Rank #1 (Strong Buy) and strong growth characteristics for investors to consider today, November 10th: